Book Thyroglobulin (TG) Test in Bengaluru

The Thyroglobulin test is a blood test that measures the level of thyroglobulin, a large glycoprotein produced exclusively by thyroid follicular cells and stored within the thyroid gland as the primary precursor for thyroid hormone synthesis. Thyroglobulin serves as the structural scaffold upon which the thyroid hormones thyroxine (T4) and triiodothyronine (T3) are assembled through iodination and coupling reactions catalysed by thyroid peroxidase. Under normal physiological conditions, small amounts of thyroglobulin are released into the bloodstream, but levels remain low in healthy individuals with an intact thyroid gland. The clinical significance of the TG test lies primarily in its role as a tumour marker for differentiated thyroid cancer, encompassing papillary thyroid carcinoma and follicular thyroid carcinoma, the two most common forms of thyroid malignancy. Following total thyroidectomy and radioiodine ablation, the thyroid gland is entirely removed or destroyed, meaning thyroglobulin should theoretically be undetectable in the blood. Any subsequent rise in TG levels therefore serves as a highly sensitive signal of residual, recurrent, or metastatic differentiated thyroid cancer, making it one of the most specific post-treatment tumour markers used in oncological surveillance. In India, thyroid cancer incidence has been rising steadily over recent decades, partly due to increased detection through improved diagnostic imaging and greater clinical awareness. The TG test is an indispensable tool for long-term cancer surveillance in thyroid cancer survivors. The test is performed on a small blood sample drawn from a vein and completed in under five minutes.

Doctors prescribe a TG test in the following situations: Monitoring differentiated thyroid cancer recurrence in patients who have undergone total thyroidectomy and radioiodine ablation where a detectable or rising TG level is the primary and earliest indicator of residual or recurrent disease, frequently prompting further imaging and intervention before clinical symptoms or radiological findings become apparent. Assessing completeness of thyroid cancer surgery where post-operative TG measurement confirms whether total thyroidectomy has been achieved, as a persistently elevated TG after surgery suggests incomplete resection of thyroid tissue or early evidence of residual malignant disease requiring further surgical or ablative treatment. Evaluating response to radioiodine ablation therapy in differentiated thyroid cancer where serial TG measurements following ablation confirm whether all remaining thyroid tissue has been successfully destroyed, with an undetectable TG indicating complete ablation and ongoing monitoring for recurrence. Investigating thyroid nodules and goitre in selected clinical contexts where TG levels alongside other thyroid investigations contribute to the overall assessment of thyroid pathology, though TG is not used as a first-line screening tool for thyroid cancer in patients with an intact thyroid gland. Detecting metastatic differentiated thyroid cancer in patients under long-term surveillance where rising TG levels trigger further investigation with thyroid ultrasound, whole body radioiodine scan, or FDG-PET CT to localise the site of recurrence or metastasis and guide treatment decisions. Monitoring thyroglobulin antibody interference in patients with positive anti-thyroglobulin antibodies where TG measurement may be falsely suppressed, and serial antibody titre trends are used alongside TG as a surrogate marker of disease status in this challenging clinical scenario.

The TG test measures the concentration of thyroglobulin in the blood, expressed in nanograms per millilitre (ng/mL). Reference ranges differ depending on whether the patient has an intact thyroid gland or has undergone thyroidectomy. In individuals with an intact thyroid, the normal reference range is 1.5 to 38.5 ng/mL. In patients who have undergone total thyroidectomy and radioiodine ablation for differentiated thyroid cancer, the target is an undetectable TG level, typically below 0.1 to 0.2 ng/mL depending on the assay used. Undetectable or Suppressed (Post-Thyroidectomy) An undetectable TG after total thyroidectomy and radioiodine ablation is the desired treatment outcome and indicates no evidence of residual or recurrent differentiated thyroid cancer at the time of testing. Continued periodic surveillance testing is maintained as per the treating oncologist's protocol given the potential for late recurrence in thyroid cancer. Low to Normal (Intact Thyroid) A result within the normal range in a patient with an intact thyroid gland indicates physiologically appropriate thyroglobulin release from functioning thyroid tissue. In this context, TG is not interpreted as a cancer marker and its clinical value is limited to specific situations such as post-surgical assessment or monitoring of known thyroid pathology. Elevated or Rising An elevated TG in a post-thyroidectomy patient, or a rising trend across serial measurements, is a clinically significant finding strongly suggesting residual thyroid tissue, recurrent differentiated thyroid cancer, or metastatic disease. The magnitude of elevation and the rate of rise guide the urgency and nature of further diagnostic imaging and oncological intervention required.

No fasting is required for the TG test, as food and fluid intake do not affect thyroglobulin levels in the blood. The test can be performed at any time of day and is typically ordered as part of a scheduled thyroid cancer surveillance visit or post-operative thyroid assessment without any specific dietary preparation. Anti-thyroglobulin antibodies, which are present in a significant proportion of patients with autoimmune thyroid disease and in some thyroid cancer patients, are known to interfere with TG measurement and can cause falsely low or undetectable results. For this reason, the TG test is ideally always ordered alongside an anti-thyroglobulin antibody measurement, and your doctor will factor antibody status into the interpretation of your TG result. Inform your doctor about current thyroid hormone replacement therapy, particularly levothyroxine dose and compliance, as TSH levels influence TG secretion and some surveillance protocols require TSH stimulation, either through levothyroxine withdrawal or recombinant TSH injection, to maximise TG sensitivity for detecting residual disease. If you are undergoing serial TG measurements for cancer monitoring, consistent use of the same laboratory and assay platform is strongly recommended as TG values are not interchangeable across different assay methods. Staying well hydrated before the blood draw facilitates easier venous access and a smooth collection experience.

If you are booking through the SecondMedic platform the Thyroglobulin test price in Bengaluru can cost you around Rs. 1309. You may also consider booking a comprehensive thyroid cancer surveillance panel that includes TG alongside anti-thyroglobulin antibodies, TSH, and Free T4 for a complete post-treatment monitoring profile at a bundled price on SecondMedic.

SecondMedic offers convenient home sample collection for the TG test in Bengaluru, making it easy to get tested without visiting a diagnostic centre. Home collection is available free of charge for orders above Rs. 300. A trained phlebotomist will visit your preferred address between 7 AM and 10 PM, seven days a week, including Sundays and public holidays. Your blood sample is processed at NABL-accredited partner laboratories, and your report is delivered within 24 hours directly to your WhatsApp and email.